标题
Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
作者
关键词
HIV integrase, Dolutegravir, Resistance to antiretrovirals, Viral fitness, Strand-transfer assay
出版物
Retrovirology
Volume 10, Issue 1, Pages 22
出版商
Springer Nature
发表日期
2013-02-23
DOI
10.1186/1742-4690-10-22
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Elvitegravir: a once-daily inhibitor of HIV-1 integrase
- (2012) Todd Wills et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dolutegravir for the treatment of HIV
- (2012) Christine Katlama et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Substitutions at Amino Acid Positions 143, 148, and 155 of HIV-1 Integrase Define Distinct Genetic Barriers to Raltegravir Resistance In Vivo
- (2012) S. Fransen et al. JOURNAL OF VIROLOGY
- Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
- (2012) Ravindra K Gupta et al. LANCET
- Multiple choices for HIV therapy with integrase strand transfer inhibitors
- (2012) Francois Raffi et al. Retrovirology
- Resistance to HIV integrase inhibitors
- (2012) Thibault Mesplède et al. Current Opinion in HIV and AIDS
- The development of novel HIV integrase inhibitors and the problem of drug resistance
- (2012) Mark A Wainberg et al. Current Opinion in Virology
- Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium
- (2011) Bach-Yen T. Nguyen et al. Annals of the New York Academy of Sciences
- Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes
- (2011) Kendra E. Hightower et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4
- (2011) Nicolas A. Margot et al. ANTIVIRAL RESEARCH
- The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype
- (2011) I. Malet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular mechanism of HIV-1 integrase-vDNA interactions and strand transfer inhibitor action: A molecular modeling perspective
- (2011) Weiwei Xue et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
- (2011) Jose-Luis Blanco et al. JOURNAL OF INFECTIOUS DISEASES
- Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir
- (2011) P. K. Quashie et al. JOURNAL OF VIROLOGY
- Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations
- (2011) H.-T. Xu et al. JOURNAL OF VIROLOGY
- Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
- (2011) Jan van Lunzen et al. LANCET INFECTIOUS DISEASES
- Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)
- (2011) S. Hare et al. MOLECULAR PHARMACOLOGY
- Development of Antiretroviral Drug Resistance
- (2011) Mark A. Wainberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation HIV-1 Integrase Inhibitor
- (2010) T. Bar-Magen et al. JOURNAL OF VIROLOGY
- Retroviral intasome assembly and inhibition of DNA strand transfer
- (2010) Stephen Hare et al. NATURE
- Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir
- (2010) Danielle Bercoff et al. Retrovirology
- Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes
- (2009) Tamara Bar-Magen et al. Retrovirology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started